Circulating DNA in the blood and its application in medical diagnosis

Molecular Biology

Volumn 42, Issue 1, 2008, Pages 9-19

  Tamkovich, S N ^a,b   Vlassov, V V ^a   Laktionov, P P ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b NOVOSIBIRSK STATE UNIVERSITY   (Russian Federation)

Author keywords

Active secretion; Apoptosis; Circulating DNA; Early noninvasive diagnosis of cancer; Necrosis; Nucleases

Indexed keywords

EID: 40849131135     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1007/s11008-008-1002-x     Document Type: Article

References (98)

1. Johnson S.M., Grosshans H., Shingara J., et al. 2005. RAS is regulated by the let-7 microRNA family. Cell. 120, 635-647.
2. Rykova E.Yu., Laktioniv P.P., Vlassov V.V. 2001. Activating effect of DNA on the immune system. Usp. Sovrem. Biol. 121, 174-185.
3. Yan Z., Lambert N.C., Ostensen M., et al. 2006. Prospective study of fetal DNA in serum and disease activity during pregnancy in women with inflammatory arthritis. Arthritis Rheum. 54, 2069-2073.
4. Tsukumo S., Yasutomo K. 2004. DNase I in pathogenesis of systemic lupus erythematosus. Clin. Immunol. 113, 14-18.
5. Ngan R.K.C., Yip T.T.C., Cheng W.W., et al. 2004. Clinical role of circulating Epstein-Barr virus DNA as a tumor marker in lymphoepithelioma-like carcinoma of the lung. Ann. N.Y. Acad. Sci. 1022, 263-270.
6. Fedchenko V.I., Gur'ev S.O., Semenova N.V. 2005. Noninvasive prenatal sex diagnosis by means of PCR. Biomed. Khim. 51, 527-535.
7. Hacker H.J., Zhang W., Tokus M., Bock T., Schroder C.H. 2004. Patterns of circulating hepatitis B virus serum nucleic acids during lamivudine therapy. Ann. N.Y. Acad. Sci. 1022, 271-281.
8. Tamkovish S.N., Laktionov P.P., Rykova E. Yu., et al. 2005. The level of extracellular nucleic acids in the blood plasma of healthy donors and patients with breast tumors. Byull. Eksp. Biol. Med. 139, 462-464.
9. Bykov V.L. 1998. Tsitologiya i obshchaya gistologiya (Cytology and General Histology). St. Petersburg: Sotis.
10. Rainer T.H., Lo Y.M., Chan L.Y., et al. 2001. Derivation of a prediction rule for posttraumatic organ failure using plasma DNA and other variables. Ann. N.Y. Acad. Sci. 945, 211-220.
11. Jahr S., Hentze H., Englisch S., et al. 2001. DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61, 1659-1665.
12. Lichtenstein A.V., Potapova G.I. 2003. Genetic defects and markers of tumor growth. Mol. Biol. 37, 181-193.
13. Nagata S. 2000. Apoptotic DNA fragmentation. Exp. Cell. Res. 256, 12-28.
14. Liu X., Li P., Widlak P., Zou H., et al. 1998. The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc. Natl. Acad. Sci. USA. 95, 8461-8466.
15. Bell D.A., Morrison B., van den Bygaart P. 1990. Immunogenic DNA-related factors: Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J. Clin. Invest. 85, 1487-1496.
16. Holdenrieder S., Stieber P., Chan L.Y.S., et al. 2005. Cell-free DNA in serum and plasma: Comparison of ELISA and quantitative PCR. Clin. Chem. 51, 1544-1546.
17. Deligezer U., Yaman F., Erten N., Dalay N. 2003. Frequent copresence of methylated DNA and fragmented nucleosomal DNA in plasma of lymphoma patients. Clin. Chim. Acta. 335, 89-94.
18. Lichtenstein A.V., Melkovyan H.S., Tomei L.D., Umansky S.R. 2001. Circulating nucleic acids and apoptosis. Ann. N.Y. Acad. Sci. 945, 239-249.
19. Laktionov P.P., Tamkovich S.N., Rykova E.Y., et al. 2004. Extracellular circulating nucleic acids in human plasma in health and disease. Nucleosides Nucleotides Nucleic Acids. 23, 879-883.
20. Lam N.Y., Rainer T.H., Chan L.Y., Joynt G.M., Lo Y.M. 2003. Time course of early and late changes in plasma DNA in trauma patients. Clin. Chem. 49, 1286-1291.
21. Skvortsova T.E., Rykova E.Y., Tamkovich S.N., et al. 2006. Cell-free and cell-bound circulating DNA in breast tumors: DNA quantification and analysis of tumor-related gene methylation. Br. J. Cancer. 94, 1492-1495.
22. Morozkin E.S., Laktionov P.P., Rykova E.Y., Vlassov V.V. 2004. Extracellular nucleic acids in cultures of long-term cultivated eukaryotic cells. Ann. N.Y. Acad. Sci. 1022, 244-249.
23. Rogers J.C., Boldt D., Kornfeld S., Skinner A., Valeri C.R. 1972. Excretion of deoxyribonucleic acid by lymphocytes stimulated with phytohemagglutinin or antigen. Proc. Natl. Acad. Sci. USA. 69, 1685-1689.
24. Anker P., Stroun M., Maurice P.A. 1975. Spontaneous release of DNA by human blood lymphoctyes as shown in an in vitro system. Cancer Res. 35, 2375-2382.
25. Stroun M., Lyautey J., Lederrey C., Olson-Sand A., Anker P. 2001. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin. Chim. Acta. 313, 139-142.
26. Merola R., Mottolese M., Orlandi G., et al. 2006. Analysis of aneusomy level and HER-2 gene copy number and their effect on amplification rate in breast cancer specimens read as 2+ in immunohistochemical analysis. Eur. J. Cancer. 42, 1501-1506.
27. Tsiambas E., Karameris A., Dervenis C., et al. 2006. HER2/neu expression and gene alterations in pancreatic ductal adenocarcinoma: A comparative immunohistochemistry and chromogenic in situ hybridization study based on tissue microarrays and computerized image analysis. J. Pancreas. 7, 283-294.
28. Combaret V., Audoynaud C., Iacono I., et al. 2002. Circulating MYCN DNA as a tumor-specific marker in neuroblastoma patients. Cancer Res. 62, 3646-3648.
29. Shaw J.-P., Kent K., Bird J., Fishback J., Froehler B. 1991. Modified deoxyoligonucleotides stable to exonuclease degradation in serum. Nucleic Acids Res. 19, 747-750.
30. Halicka H.D., Bedner E., Darzynkiewicz Z. 2000. Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis. Exp. Cell Res. 260, 248-256.
31. Ng E.K., Tsui N.B., Lam N.Y., et al. 2002. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin. Chem. 48, 1212-1217.
32. Holdenrieder S., Stieber P. 2004. Therapy control in oncology by circulating nucleosomes. Ann. N.Y. Acad. Sci. 1022, 211-216.
33. Butler P.J., Tennent G.A., Pepys M.B. 1990. Pentraxin-chromatin interactions: Serum amyloid P component specifically displaces H1-type histones and solubilizes native long chromatin. J. Exp. Med. 172, 13-18.
34. Egorova V.A., Blinov M.N. 1993. DNA-binding serum proteins in hemoblastosis. Vopr. Med. Khim. 39, 36-38.
35. Gerasimova Y.V., Alekseyeva I.V., Bogdanova T.G., et al. 2006. Affinity separation of polyribonucleotide-binding human blood proteins. Bioorg. Med. Chem. Lett. 16, 5526-5529.
36. Pautova L.V., Rykova E.Yu., Laktionov P.P., Vlasov V.V. 1996. Analysis of the interaction of polyvalent antibodies with nucleic acids using alkylating oligonucleotide derivatives. Mol. Biol. 30, 941-950.
37. Laktionov P.P., Bryksin A.V., Rykova E.Yu., Vlassov V.V. 1999. In vivo analysis of oligonucleotide-protein interactions in the blood. Byull. Eksp. Biol. Med. 127, 654-657.
38. Van Schravendijk M.R., Dwek R.A. 1982. Interaction of C1q with DNA. Mol. Immunol. 19, 1179-1187.
39. Hoch S.O. 1982. DNA-binding domains of fibronectin probed using Western blots. Biochem. Biophys. Res. Commun. 106, 1353-1358.
40. Laktionov P.P., Rykova E., Krepkii D.V., Bryksin A.V., Vlassov V.V. 1997. Interactions of oligonucleotides with proteins of barrier fluids. Biokhimiya. 62, 716-723.
41. Zou S., Magura C.E., Hurley W.L. 1992. Heparin-binding properties of lactoferrin and lysozyme. Comp. Biochem. Physiol. B. 103, 889-895.
42. 2+-dependent interaction of DNA with eukaryotic cells. Mol. Biol. 22, 1667-1672.
43. Budker V.G., Godovikov A.A., Naumova L.P., Slepneva I.A. 1980. Interaction of polynucleotides with natural and model membranes. Nucleic Acids Res. 8, 2499-2515.
44. Tamkovich S.N., Bryzgunova O.E., Rykova E.Y., et al. 2005. Circulating nucleic acids in blood of healthy male and female donors. Clin. Chem. 51, 1317-1319.
45. Chelobanov B.P., Laktionov P.P., Vlassov V.V. 2006. Proteins involved in nucleic acid binding and uptake by cells. Biokhimiya. 71, 725-741.
46. Gasparro F.P., Dall'Amico R., O'Malley M., Heald P.W., Edelson R.L. 1990. Cell membrane DNA: A new target for psoralen photoadduct formation. Photochem. Photobiol. 52, 315-321.
47. Laktionov P.P., Dazard J.E., Vives E., et al. 1999. Characterization of membrane oligonucleotide-binding proteins and oligonucleotide uptake in keratinocytes. Nucleic Acids Res. 27, 2315-2324.
48. Laktionov P.P., Rykova E., Vlassov V.V. 1997. Involvement of surface immunoglobulins in lymphocyte activation under the effect of plasmid DNA. Mol. Biol. 31, 506-514.
49. Huss R. 1988. A 42 kDa erythrocyte surface membrane protein with binding capacity to polynucleotides shows functional lack in systemic lupus erythematosus. Immunobiology. 178, 141-142.
50. Dorsch C.A. 1981. Binding of single-strand DNA to human platelets. Thromb. Res. 24, 119-129.
51. Geselowitz D.A., Neckers L.M. 1995. Bovine serum albumin is a major oligonucleotide-binding protein found on the surface of cultured cells. Antisense Res. Dev. 5, 213-217.
52. Laktionov P.P., Tamkovich S.N., Rykova E.Y., et al. 2004. Free and cell surface bound nucleic acids in blood of healthy donors and breast cancer patients. Ann. N.Y. Acad. Sci. 1022, 221-227.
53. Cherepanova A.V., Tamkovich S.N., Vlassov V.V., Laktionov P.P. 2007. Deoxyribonuclease activity in blood in health and diseases. Biochemistry (Moscow). Suppl. Ser. B: Biomed. Chem. 1, 320-330.
54. Klishko E.V., Kondakova I.V., Choinozov E.L. 2003. Matrix metalloproteins in carcinogenesis. Sib. Onkol. Zh. 2, 63-70.
55. Tamkovich S.N., Cherepanova A.V., Kolesnikova E.V., et al. 2006. Circulating DNA and DNAse activity in human blood. Ann. N.Y. Acad. Sci. 1075, 191-196.
56. Baranovskii A.G., Buneva V.N., Nevinskii G.A. 2004. Human deoxyribonucleases. Biokhimiya. 69, 725-742.
57. Pan C.Q., Sinicropi D.V., Lazarus R.A. 2001. Engineered properties and assays for human DNase I mutants. Methods Mol. Biol. 160, 309-321.
58. Dewez B., Lans M., Allaeys V., et al. 1993. Serum alkaline deoxyribonuclease activity, a sensitive marker for the therapeutic monitoring of cancer patients: Methodological aspects. Eur. J. Clin. Chem. Clin. Biochem. 31, 793-797.
59. Yasuda T., Takeshita H., Nakazato E., et al. 1998. Activity measurement for deoxyribonucleases I and II with picogram sensitivity based on DNA/SYBR Green I fluorescence. Anal. Biochem. 255, 274-276.
60. Abasheva G.K., Gubko A.A., Petrusenko G.P., Prasmytskii O.T. 1994. Nuclease activities in multiple trauma. Vopr. Med. Khim. 40, 30-31.
61. Frittitta L., Camastra S., Baratta R., et al. 1999. A soluble PC-1 circulates in human plasma: Relationship with insulin resistance and associated abnormalities. J. Clin. Endocrinol. Metab. 84, 3620-3625.
62. Kanyshkova T.G., Babina S.E., Semenov D.V., et al. 2003. Multiple enzymic activities of human milk lactoferrin. Eur. J. Biochem. 270, 3353-3361.
63. Odintsova E.S., Kharitonova M.A., Baranovskii A.G., et al. 2006. DNA-hydrolyzing IgG antibodies from the blood of patients with the acquired immunodeficiency syndrome. Mol. Biol. 40, 857-864.
64. Zendegui J.G., Vasquez K.M., Tinsley J.H., Kessler D.J., Hogan M.E. 1992. In vivo stability and kinetics of absorption and disposition of 3' phosphopropyl amine oligonucleotides. Nucleic Acids Res. 20, 307-314.
65. Emlen W., Mannik M. 1978. Kinetics and mechanisms for removal of circulating single-stranded DNA in mice. J. Exp. Med. 147, 684-699.
66. Gauthier V.J., Tyler L.N., Mannik M. 1996. Blood clearance kinetics and liver uptake of mononucleosomes in mice. J. Immunol. 156, 1151-1156.
67. Agrawal S., Temsamani J., Tang J. Y. 1991. Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc. Natl. Acad. Sci. USA. 88, 7595-7599.
68. Tsumita T., Iwanaga M. 1963. Fate of injected deoxyribonucleic acid in mice. Nature. 198, 1088-1089.
69. Lo Y.M., Zhang J., Leung T.M., et al. 1999. Rapid clearance of fetal DNA from maternal plasma. Am. J. Hum. Genet. 64, 218-224.
70. Bryzgunova O.E., Skvortsova T.E., Kolesnikova E.V., et al. 2006. Isolation and comparative study of cell-free nucleic acids from human urine. Ann. N.Y. Acad. Sci. 1075, 334-340.
71. Steinman C.R. 1975. Free DNA in serum and plasma from normal adults. J. Clin. Invest. 56, 512-515.
72. Raptis L., Menard H. 1980. Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J. Clin. Invest. 66, 1391-1399.
73. Shapiro B., Chakrabarty M., Cohn E.M., Leon S.A. 1983. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer. 51, 2116-2120.
74. Stroun M., Anker P., Maurice P., et al. 1989. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology. 46, 318-322.
75. Silva J.M., Dominguez G., Garcia J.M., et al. 1999. Presence of tumor DNA in plasma of breast cancer patients: Clinicopathological correlations. Cancer Res. 59, 3251-3256.
76. Shevchuk N.A. 2001. Time-allowed immunofluorescent analysis for DNA and tests for DNA content in human plasma. Vopr. Med. Khim. 47, 439-448.
77. Sozzi G., Conte D., Mariani L., et al. 2001. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res. 61, 4675-4678.
78. Wu T.L., Zhang D., Chia J.H., et al. 2002. Cell-free DNA: Measurement in various carcinomas and establishment of normal reference range. Clin. Chim. Acta. 321, 77-87.
79. Chang H.W., Lee S.M., Goodman S.N., et al. 2002. Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer. J. Natl. Cancer Inst. 94, 1697-1703.
80. Wong T.S., Kwong D.L., Sham J.S., et al. 2004. Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma. Clin. Cancer Res. 10, 2401-2406.
81. Vasilyeva I.N. 2001. Low-molecular-weight DNA in blood plasma as an index of the influence of ionizing radiation. Ann. N. Y. Acad. Sci. 945, 221-228.
82. Lam N.Y., Rainer T.H., Chan L.Y., Joynt G.M., Lo Y.M. 2003. Time course of early and late changes in plasma DNA in trauma patients. Clin. Chem. 49, 1286-1291.
83. Steinman C.R. 1979. Circulating DNA in systemic lupus erythematosus. Association with central nervous system involvement and systemic vasculitis. Am. J. Med. 67, 429-435.
84. Anker P., Mulcahy H., Stroun M. 2003. Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: Time for large-scale clinical studies. Int. J. Cancer. 103, 149-152.
85. Tamkovich S.N., Bryzgunova O.E., Rykova E.Yu., et al. 2005. Circulating nucleic acids in the blood of patients with stomach and colon cancer. Biomed. Khim. 51, 321-328.
86. Lo Y.M., Leung S.F., Chan L.Y., et al. 2000. Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma. Cancer Res. 60, 2351-2355.
87. Fiegl H., Millinger S., Mueller-Holzner E., et al. 2005. Circulating tumor-specific DNA: A marker for monitoring efficacy of adjuvant therapy in cancer patients. Cancer Res. 65, 1141-1145.
88. Tamkovich S.N., Laktionov P.P., Bryzgunova O.E., et al. 2005. The level of extracellular nucleic acids associated with the surface of blood cells in diagnosis of breast cancer. Mol. Med. 2, 46-50.
89. Goessl C., Krause H., Muller M., et al. 2000. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. Cancer Res. 60, 5941-5945.
90. Frattini M., Gallino G., Signoroni S., et al. 2006. Quantitative analysis of plasma DNA in colorectal cancer patients. Ann. N. Y. Acad. Sci. 1075, 185-190.
91. Muller I., Urban K., Pantel K., Schwarzenbach H. 2006. Comparison of genetic alterations detected in circulating microsatellite DNA in blood plasma samples of patients with prostate cancer and benign prostatic hyperplasia. Ann. N.Y. Acad. Sci. 1075, 222-229.
92. Chen X.Q., Stroun M., Magnenat J.L., et al. 1996. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med. 2, 1033-1035.
93. Sanchez-Cespedes M., Esteller M., Wu L., et al. 2000. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res. 60, 892-895.
94. Xue X., Zhu Y.M., Woll P.J. 2006. Circulating DNA and lung cancer. Ann. N.Y. Acad. Sci. 1075, 154-164.
95. Sorenson G.D., Pribish D.M., Valone F.H., et al. 1994. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol. Biomarkers Prev. 3, 67-71.
96. Lichtenstein A.V., Kisseleva N.P. 2001. DNA methylation and carcinogenesis. Biokhimiya. 66, 293-317.
97. Goessl C., Muller M., Heicappell R., Krause H., Miller K. 2001. DNA-based detection of prostate cancer in blood, urine, and ejaculates. Ann. N.Y. Acad. Sci. 945, 51-58.
98. Wong T., Kwong D., Sham J., et al. 2004. Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma. Clin. Cancer Res. 10, 2401-2406.